Covalent diabodies and uses thereof

Details for Australian Patent Application No. 2006236439 (hide)

Owner Macrogenics, Inc.

Inventors Huang, Ling; Johnson, Leslie S.

Agent Fisher Adams Kelly

Pub. Number AU-B-2006236439

PCT Pub. Number WO2006/113665

Priority 60/671,657 15.04.05 US

Filing date 17 April 2006

Wipo publication date 26 October 2006

Acceptance publication date 3 May 2012

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/113665 Priority application(s): WO2006/113665

3 May 2012 Application Accepted

  Published as AU-B-2006236439

30 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236441-Therapeutic peptides for the treatment of metastatic cancer

2006236428-System and related method for determining a measurement between locations on a body